Table 2 Laboratory and radiographic findings of the patients with tuberculous pleurisy
| Â | Isolated pleurisy group (N = 51) | Pleuro-pulmonary group(N = 154) | p value |
|---|---|---|---|
Positive AFB in PE | 1 (2%) | 4 (8%) | 1.000 |
Receiving pleura biopsy | 35 (69%) | 51 (33%) | < 0.001 |
   Granulomatous inflammation | 25 (71%) | 40 (78%) | 0.458 |
Pretreatment resistance pattern | Â | Â | Â |
   Anyone-drug resistance | 5 (10%) | 14 (9%) | 0.837 |
Isoniazid | 4 (8%) | 13 (8%) | 0.931 |
Rifampicin | 1 (2%) | 3 (2%) | 0.977 |
Ethambutol | 2 (4%) | 4 (3%) | 0.605 |
   Multidrug resistance | 1 (2%) | 3 (2%) | 0.977 |
Radiographic findings | Â | Â | Â |
   Bilateral lesions | 5 (10%) | 61 (40%) | < 0.001 |
   Loculated PE | 22 (43%) | 23 (15%) | < 0.001 |
PE analysis | Â | Â | Â |
   Leukocyte (/μL) | 3016 [5297] | 1938 [4649] | 0.239 |
   Lymphocyte (%) | 82 [24] | 75 [25] | 0.092 |
   Neutrophil (%) | 11 [18] | 17 [21] | 0.096 |
   Total protein (g/dL) | 4.6 [1.0] | 4.2 [3.1] | 0.264 |
   Lactate dehydrogenase (U/L) | 965 [593] | 1166 [1837] | 0.292 |
   Glucose (mg/dL) | 87 [42] | 104 [62] | 0.202 |
Blood tests | Â | Â | Â |
   Leukocyte > 11000 or < 4000/μL | 6 (12%) | 29 (19%) | 0.286 |
   Anemia | 21 (41%) | 98 (60%) | 0.003 |
   Albumin < 3.5 g/dL | 19 (37%) | 83 (54%) | 0.007 |
   Total bilirubin > 1.2 mg/dL | 5 (10%) | 20 (13%) | 0.800 |